المؤلفون: Kluger, Aaron Y, Tecson, Kristen M, Lee, Andy Y, Lerma, Edgar V, Rangaswami, Janani, Lepor, Norman E, Cobble, Michael E, McCullough, Peter A

المصدر: Cardiovascular Diabetology. 18(1)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Cardiovascular, Clinical Research, Kidney Disease, Clinical Trials and Supportive Activities, Diabetes, Heart Disease, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Good Health and Well Being, Benzhydryl Compounds, Canagliflozin, Cardiovascular Diseases, Cardiovascular System, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Disease Progression, Glucosides, Humans, Kidney, Protective Factors, Randomized Controlled Trials as Topic, Renal Insufficiency, Chronic, Risk Assessment, Risk Factors, Sodium-Glucose Transporter 2 Inhibitors, Time Factors, Treatment Outcome, SGLT2 inhibitor, Empagliflozin, Dapagliflozin, CANVAS, EMPA-REG OUTCOME, DECLARE-TIMI 58, CREDENCE, Cardiovascular outcome trials, Heart failure hospitalization, Cardiovascular death, Albuminuria, Estimated glomerular filtration function, Chronic kidney disease, End-stage renal disease, Mortality, EMPA–REG OUTCOME, Cardiorespiratory Medicine and Haematology, Cardiovascular System & Hematology, Cardiovascular medicine and haematology

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/3pw2b91fTest

المؤلفون: Lepor, Norman E.

المصدر: Reviews in Cardiovascular Medicine; Fall2007, Vol. 8 Issue 4, p220-227, 8p, 1 Diagram, 3 Charts, 5 Graphs

المؤلفون: Lepor, Norman E.

المصدر: Reviews in Cardiovascular Medicine; Spring2007, Vol. 8 Issue 2, p90-100, 11p, 10 Charts, 1 Graph

المؤلفون: Stone, Gregg W., McCullough, Peter A., Tumlin, James A., Lepor, Norman E., Madyoon, Hooman, Murray, Patrick, Wang, Andrew, Chu, A. Alan, Schaer, Gary L., Stevens, Melissa, Wilensky, Robert L., O'Neill, William W.

المصدر: JAMA: Journal of the American Medical Association; 11/5/2003, Vol. 290 Issue 17, p2284-2291, 8p

مصطلحات موضوعية: KIDNEY diseases, CARDIOVASCULAR diseases, CHRONIC kidney failure, CLINICAL trials, MORTALITY, HEMODYNAMICS, CATECHOLAMINES, NEUROTRANSMITTERS, DOPAMINE, PLACEBOS, DIABETES